BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21095127)

  • 41. Synthesis, antifungal activity, and structure-activity relationships of coruscanone A analogues.
    Babu KS; Li XC; Jacob MR; Zhang Q; Khan SI; Ferreira D; Clark AM
    J Med Chem; 2006 Dec; 49(26):7877-86. PubMed ID: 17181171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and SAR study of 3-(benzo[d][1,3]dioxol-5-yl)-N-benzylpropanamide as novel potent synergists against fluconazole-resistant Candida albicans.
    Cai Z; Ding Z; Hao Y; Ni T; Xie F; Zhao J; Li R; Yu S; Wang T; Chai X; Jin Y; Gao Y; Zhang D; Jiang Y
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4571-4575. PubMed ID: 28874321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microwave assistant one pot synthesis, crystal structure, antifungal activities and 3D-QSAR of novel 1,2,4-triazolo[4,3-a]pyridines.
    Liu XH; Sun ZH; Yang MY; Tan CX; Weng JQ; Zhang YG; Ma Y
    Chem Biol Drug Des; 2014 Sep; 84(3):342-7. PubMed ID: 24636488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel conformationally restricted triazole derivatives with potent antifungal activity.
    Wang W; Wang S; Liu Y; Dong G; Cao Y; Miao Z; Yao J; Zhang W; Sheng C
    Eur J Med Chem; 2010 Dec; 45(12):6020-6. PubMed ID: 20950895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides.
    Zhuravel' IO; Kovalenko SM; Ivachtchenko AV; Balakin KV; Kazmirchuk VV
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5483-7. PubMed ID: 16183276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Synthesis and antifungal activity of 1-(1,2,4-triazolyl-1H-1-yl)-2-(2,4-diflurophenyl)-3-(4-substituted benzyl-1-piperazinyl)-2-propanols].
    Sheng CQ; Zhang WN; Ji HT; Song YL; Yang S; Zhou YJ; Zhu J; Lü JG
    Yao Xue Xue Bao; 2003 Sep; 38(9):665-70. PubMed ID: 14730915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of using collagen as the base of the antifungal drug, miconazole.
    Yoshida K; Hirai K; Ara T; Ito M; Wang PL; Igarashi Y
    J Oral Rehabil; 2006 May; 33(5):363-7. PubMed ID: 16629895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and characterization of (Z)-N-(1-[2-{3-[(dimethylamino)methyl)]-2-methoxyphenyl}-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl]ethylidene) benzenamine derivatives as potent antifungal agents.
    Malhotra M; Hans P; Sharma S; Deep A; Phogat P
    Acta Pol Pharm; 2012; 69(3):433-8. PubMed ID: 22594257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives.
    Srinivasan S; Beema Shafreen RM; Nithyanand P; Manisankar P; Pandian SK
    Eur J Med Chem; 2010 Dec; 45(12):6101-5. PubMed ID: 20933306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species.
    Çavuşoğlu BK; Yurttaş L; Cantürk Z
    Eur J Med Chem; 2018 Jan; 144():255-261. PubMed ID: 29274492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
    Kurnatowska AK; Kwaśniewska J
    Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives.
    Chen CJ; Song BA; Yang S; Xu GF; Bhadury PS; Jin LH; Hu DY; Li QZ; Liu F; Xue W; Lu P; Chen Z
    Bioorg Med Chem; 2007 Jun; 15(12):3981-9. PubMed ID: 17452108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.
    Liu H; Wang L; Li Y; Liu J; An M; Zhu S; Cao Y; Jiang Z; Zhao M; Cai Z; Dai L; Ni T; Liu W; Chen S; Wei C; Zang C; Tian S; Yang J; Wu C; Zhang D; Liu H; Jiang Y
    ChemMedChem; 2014 Jan; 9(1):207-16. PubMed ID: 24376206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents.
    Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; D'Ascenzio M; Lilli D; Rivanera D
    Eur J Med Chem; 2011 Jan; 46(1):378-82. PubMed ID: 21084135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereoselective synthesis and in vitro antifungal evaluation of (E)- and (Z)-imidazolylchromanone oxime ethers.
    Emami S; Falahati M; Banifatemi A; Moshiri K; Shafiee A
    Arch Pharm (Weinheim); 2002 Jul; 335(7):318-24. PubMed ID: 12207281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
    Batovska D; Parushev S; Slavova A; Bankova V; Tsvetkova I; Ninova M; Najdenski H
    Eur J Med Chem; 2007 Jan; 42(1):87-92. PubMed ID: 17007965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diversity-oriented synthesis of pyrazoles derivatives from flavones and isoflavones leads to the discovery of promising reversal agents of fluconazole resistance in Candida albicans.
    Cui CY; Liu J; Zheng HB; Jin XY; Zhao XY; Chang WQ; Sun B; Lou HX
    Bioorg Med Chem Lett; 2018 May; 28(9):1545-1549. PubMed ID: 29606575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents.
    Borate HB; Maujan SR; Sawargave SP; Chandavarkar MA; Vaiude SR; Joshi VA; Wakharkar RD; Iyer R; Kelkar RG; Chavan SP; Kunte SS
    Bioorg Med Chem Lett; 2010 Jan; 20(2):722-5. PubMed ID: 19963383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.